drug
as of 2026-07-01Pimozide
MeSH D010868
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hannover Medical School
5 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
SchizophreniaDepressionPsychosomatic DisordersSchizophrenia Spectrum and Other Psychotic DisordersSchizophreniaAnxiety DisordersDepressionPsychotic DisordersPsychotic DisordersSchizoaffective DisordersPsychophysiologic DisordersDementiaAnxiety DisordersSchizophrenia and Disorders With Psychotic FeaturesDementia
Trials
5
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
NCT02600741—Completed
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
NCT02307396Phase 4Completed
Efficacy of Pimozide Augmentation for Clozapine Partial Response
NCT00374244Phase 2Completed
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
NCT00158223Phase 4Completed
KOLs & investigators
5
Stefan Leucht, ProfessorKOL score 87
Joseph I. Friedman, MDKOL score 5
Helge Frieling, Prof., MDKOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
KOL
Stefan Leucht, Professor
personKOL score 87
Joseph I. Friedman, MD
personKOL score 5
Helge Frieling, Prof., MD
personKOL score 5
Handan Gunduz-Bruce, MD, MBA
personKOL score —